ArticleBMJ open2021

Efficacy of anti-TNF dosing interval lengthening in adolescents and young adults with inflammatory bowel disease in sustained remission (FREE-study): protocol for a partially randomised patient preference trial.

Marleen Bouhuys et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.